abstract
Future of Health Summit 2024

Part 2: A Glimpse Ahead: The Future of R&D

-

Scientific and technological innovations will continue to change the lifecycle of drug development, from discovery to clinical trials and commercialization, with the promise to prevent and treat diseases in new ways. These innovations might hold the key to precision and individualized medicine. This session will bring together leaders to discuss the emerging technologies that are reshaping drug development and the practical impact these technologies are expected to have on accelerating development timelines, reducing R&D costs, and improving the health ecosystem.

    Moderator

    Image

    Conor Hale

    Senior Editor, Fierce Medtech

    Speakers

    Image

    Theresa LaVallee

    Chief Development Officer, Coherus BioSciences
    Image

    Joni Rutter

    Director, National Center for Advancing Translational Sciences, National Institutes of Health
    Image

    Laurence Sperling

    Chief Medical Officer, Family Heart Foundation
    Image

    Peter Stein

    Director, Office of New Drugs, US Food and Drug Administration